New Challenges in the Study of Diabetes and Related Complications-Pathophysiology, Prevention and Treatment
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 575
Special Issue Editor
Interests: diabetes mellitus; lipid metabolism; diabetes mellitus type 1; diabetes mellitus type 2; diabetes complications; diabetic kidney disease; metabolic dysfunction-associated fatty liver disease; non-alcoholic fatty liver disease; nutrition; glucose variability
Special Issue Information
Dear Colleagues,
Diabetes mellitus remains one of the most prevalent non-communicable diseases in the developed world. Despite the ability to control for the main risk factors of diabetes complications, such as hypertension, hyperglycemia, and hyperlipidemia, a lot of patients progress to severe forms of diabetic kidney disease, diabetic retinopathy, and cardiovascular disease. Therefore, novel approaches are needed to improve the outcomes of patients undergoing already available pharmacotherapy. New therapeutic options should be targeted to achieve better glycemic control and decrease systemic low-grade inflammation and oxidative stress. Drugs targeting impaired microvasculature and macrovasculature are also needed. These may include, but are not limited to, antibodies against molecules inducing vascular damage, compounds targeting anti-oxidative defense, and others.
This Special Issue, New Challenges in the Study of Diabetes and Related Complications: Pathophysiology and Treatment, welcomes submissions on the topic of diabetes and its complications, including the pathophysiology, prevention, and treatment of these diseases.
Dr. Jeļizaveta Sokolovska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes mellitus
- glucose variability
- complications of diabetes
- low-grade inflammation
- oxidative stress
- anti-oxidative response
